Residence time with Fibro technology is measured in seconds, because binding properties do not depend on flow rate. This rapid purification enables high-throughput screening for monoclonal antibody (mAb) candidate drugs and cell lines.
Screening and optimization of process parameters can be achieved quickly using Fibro technology. More samples can be purified faster and with more information-rich results compared with other formats and technologies.
Fibro chromatography is based on electrospun cellulose fibers that enables the combination of high flow rates with high binding capacity. This technology offers new opportunities for flexible, high-productivity purification solutions from process development to manufacturing scale.
